Faster diagnosis and care for HIV-related Kaposi sarcoma in East Africa
Project 2: Rapid Case Ascertainment as a Tool for Epidemiologic Investigation and Efficient Linkage to Care in HIV-infected Patients Diagnosed with Kaposi Sarcoma in East Africa
This project helps identify people with HIV who develop Kaposi sarcoma in East Africa and connects them quickly to medical care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11416275 on NIH RePORTER |
What this research studies
If you have HIV and are diagnosed with Kaposi sarcoma, this project uses rapid case-finding to locate newly diagnosed patients and learn more about how and where the cancer appears. Teams work with local clinics and hospitals to gather information, track patterns of disease, and speed up referrals to treatment. The program includes outreach and care-navigation so patients are linked to oncology and HIV services sooner. Researchers will follow outcomes to see if faster identification and linkage improve treatment access and health.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV in participating East African clinics who are newly diagnosed with Kaposi sarcoma or suspected to have it.
Not a fit: People without HIV, without Kaposi sarcoma, or those living outside the participating East African areas are unlikely to directly benefit from this project.
Why it matters
Potential benefit: If successful, this could shorten the time between diagnosis and getting cancer and HIV treatment, which may improve health outcomes.
How similar studies have performed: Other programs using rapid case-finding and active linkage to care for HIV and some cancers have improved time to treatment, though applying these methods specifically to Kaposi sarcoma in East Africa is less common.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Byakwaga, Helen — University of California, San Francisco
- Study coordinator: Byakwaga, Helen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.